Cargando…

Osteopontin is Critical for Hyperactive mTOR-Induced Tumorigenesis in Oral Squamous Cell Carcinoma

Mechanistic target of rapamycin (mTOR) plays a critical role in the development of oral squamous cell carcinoma (OSCC), but the underlying mechanisms remain poorly understood. Here we have demonstrated that the expression of osteopontin (OPN) was dramatically up-regulated in OSCC tissues and cell li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gan, Ning, Zou, Sihai, Hang, Wenming, Yang, Deqin, Zhang, Xuemei, Yin, Yibing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479241/ https://www.ncbi.nlm.nih.gov/pubmed/28638450 http://dx.doi.org/10.7150/jca.18031

Ejemplares similares

Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy
por: Yuan, RuiRong, et al.
Publicado: (2009)

RICTOR/mTORC2 affects tumorigenesis and therapeutic efficacy of mTOR inhibitors in esophageal squamous cell carcinoma
por: Lu, Zhaoming, et al.
Publicado: (2020)

Normalizing a hyperactive mTOR initiates muscle growth during obesity
por: Williamson, David L., et al.
Publicado: (2011)

Depdc5 knockdown causes mTOR‐dependent motor hyperactivity in zebrafish
por: de Calbiac, Hortense, et al.
Publicado: (2018)

ubtor Mutation Causes Motor Hyperactivity by Activating mTOR Signaling in Zebrafish
por: Wang, Tiantian, et al.
Publicado: (2021)

MYC Cooperates with AKT in Prostate Tumorigenesis and Alters Sensitivity to mTOR Inhibitors
por: Clegg, Nicola J., et al.
Publicado: (2011)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

Lysosomal TMEM9‐LAMTOR4‐controlled mTOR signaling integrity is required for mammary tumorigenesis
por: Zhang, Shengzhe, et al.
Publicado: (2022)

LIF promotes tumorigenesis and metastasis of breast cancer through the AKT-mTOR pathway
por: Li, Xiaoyan, et al.
Publicado: (2014)

Osteopontin and oral carcinogenesis
por: Kapoor, Shailendra
Publicado: (2008)

mTOR hyperactivity mediates lysosomal dysfunction in Gaucher's disease iPSC-neuronal cells
por: Brown, Robert A., et al.
Publicado: (2019)

The role of metabolic ecosystem in cancer progression — metabolic plasticity and mTOR hyperactivity in tumor tissues
por: Sebestyén, Anna, et al.
Publicado: (2022)

Osteopontin Involves Cisplatin Resistance and Poor Prognosis in Oral Squamous Cell Carcinoma
por: Luo, Sheng-Dean, et al.
Publicado: (2015)

Immunolocalization of osteopontin in dysplasias and squamous cell carcinomas arising from oral epithelium
por: Aravind, Thara, et al.
Publicado: (2017)

Roles of Src family kinase, Ras, and mTOR signaling in intestinal epithelial homeostasis and tumorigenesis
por: Matozaki, Takashi, et al.
Publicado: (2020)

Anti-Apoptotic Effects of Osteopontin via the Up-Regulation of AKT/mTOR/β-Catenin Loop in Acute Myeloid Leukemia Cells
por: Zahed Panah, Mahdi, et al.
Publicado: (2017)

PSMD7 downregulation induces apoptosis and suppresses tumorigenesis of esophageal squamous cell carcinoma via the mTOR/p70S6K pathway
por: Shi, Ke, et al.
Publicado: (2018)

Hyperactive ERK and persistent mTOR signaling characterize vemurafenib resistance in papillary thyroid cancer cells
por: Hanly, Elyse K., et al.
Publicado: (2015)

RHEB/mTOR hyperactivity causes cortical malformations and epileptic seizures through increased axonal connectivity
por: Proietti Onori, Martina, et al.
Publicado: (2021)

Glomerular Damage in Trichloroethylene-Sensitized Mice: Targeting Cathepsin L-Induced Hyperactive mTOR Signaling
por: Wang, Feng, et al.
Publicado: (2021)

From attention-deficit hyperactivity disorder to sporadic Alzheimer’s disease—Wnt/mTOR pathways hypothesis
por: Grünblatt, Edna, et al.
Publicado: (2023)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

SLFN11 inhibits hepatocellular carcinoma tumorigenesis and metastasis by targeting RPS4X via mTOR pathway
por: Zhou, Chenhao, et al.
Publicado: (2020)

Irisin inhibits pancreatic cancer cell growth via the AMPK-mTOR pathway
por: Liu, Jiayu, et al.
Publicado: (2018)

Expression of Osteopontin in oesophageal squamous cell carcinoma
por: Kita, Y, et al.
Publicado: (2006)

Detoxified pneumolysin derivative ΔA146Ply inhibits autophagy and induces apoptosis in acute myeloid leukemia cells by activating mTOR signaling
por: Zhu, Tao, et al.
Publicado: (2022)

Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma
por: Chakraborty, Sanjukta, et al.
Publicado: (2008)

Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis
por: Li, Shuangjiang, et al.
Publicado: (2016)

The Roles of Post-Translational Modifications on mTOR Signaling
por: Yin, Shasha, et al.
Publicado: (2021)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

Prognostic Significance of mTOR and PTEN in Patients with Esophageal Squamous Cell Carcinoma
por: Lu, Jianjun, et al.
Publicado: (2015)

Identification of mTOR inhibitor-resistant genes in cutaneous squamous cell carcinoma
por: Yu, Seong-Lan, et al.
Publicado: (2018)

mTOR is critical for intestinal T-cell homeostasis and resistance to Citrobacter rodentium
por: Lin, Xingguang, et al.
Publicado: (2016)

MicroRNA-144-3p Inhibits Tumorigenesis of Oral Squamous Cell Carcinoma by downregulating ERO1L
por: Li, Xian, et al.
Publicado: (2020)

mTOR Suppresses Macroautophagy During Striatal Postnatal Development and Is Hyperactive in Mouse Models of Autism Spectrum Disorders
por: Lieberman, Ori J., et al.
Publicado: (2020)

Lkb1 and Pten Synergise to Suppress mTOR-Mediated Tumorigenesis and Epithelial-Mesenchymal Transition in the Mouse Bladder
por: Shorning, Boris Y., et al.
Publicado: (2011)

HKDC1 promotes the tumorigenesis and glycolysis in lung adenocarcinoma via regulating AMPK/mTOR signaling pathway
por: Wang, Xinyu, et al.
Publicado: (2020)

mTOR/Raptor signaling is critical for skeletogenesis in mice through the regulation of Runx2 expression
por: Dai, Qinggang, et al.
Publicado: (2017)

Loss of the clock gene Per1 promotes oral squamous cell carcinoma progression via the AKT/mTOR pathway
por: Yang, Guojun, et al.
Publicado: (2020)

FOXD1-mTOR Signaling Pathway on Oral Squamous Cell Carcinoma and Its Inhibition by Rosemary Extract (Invitro-Study)
por: El-din, Yasmine Alaa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lj9dfiv780odlgtks0npbbnk4e